Rates of psychotropic drugs1 | |||
2008–2012 | 1996–2004 | ||
N = 87 | N = 142 | Fisher’s exact (p value) | |
antipsychotics | 46 | 37.3 | 0.2139 |
antidepressants | 67.8 | 56.3 | 0.0953 |
hypnotics / sedatives | 24,1 | 24,6 | 10.000 |
mood stabilizers | 9.2 | 24.6 | 0.0048 |
valproic acid | 3.4 | 2.8 | |
carbamazepine | 3.4 | 20.4 | |
lamotrigine | 2.3 | 0 | |
naltrexone | 35.6 | 6.3 | < 0.0001 |
overall | 94 | 71.8 | < 0.0001 |
Rates of antipsychotics2 | |||
2008–2012 | 1996–2004 | ||
N = 40 | N = 53 | Fisher’s exact (p value) | |
low-potency antipsychotics | 42.5 | 83 | < 0.0001 |
high-potency antipsychotics | 5 | 17 | 0.1073 |
second generation antipsychotics | 60 | 43.3 | 0.1438 |
Rates of antidepressants3 | |||
2008–2012 | 1996–2004 | ||
N = 59 | N = 80 | Fisher’s exact (p value) | |
tri−/tetracyclic antidepressants | 13.6 | 53.8 | < 0.0001 |
SSRI | 55.9 | 56.3 | 0.9702 |
MAO inhibitors | 0 | 11.3 | |
atypical antidepressants | 42.4 | 37.5 | 0.6013 |